GENTEX CORP (GNTX)
US3719011096 - Common Stock
26.64 -0.34 (-1.26%)
Fundamental Rating
Overall GNTX gets a fundamental rating of 7 out of 10. We evaluated GNTX against 46 industry peers in the Automobile Components industry. GNTX gets an excellent profitability rating and is at the same time showing great financial health properties. While showing a medium growth rate, GNTX is valued expensive at the moment.
Profitability
Profitability Rating
GNTX's Return On Assets of 16.85% is amongst the best returns of the industry. GNTX outperforms 96% of its industry peers. The industry average Return On Assets is 3.78%.
GNTX's Return On Equity of 19.31% is amongst the best returns of the industry. GNTX outperforms 88% of its industry peers. The industry average return on equity is 8.91%.
GNTX has a Profit Margin of 16.60%. This is amongst the best returns in the industry. The industry average is 3.89%. GNTX outperforms 100% of its industry peers.
GNTX has a Piotroski-F score of 5.00. This indicates an average health and profitability for GNTX.
VS Industry
ROA (16.85%) VS Industry: 96% outperformed.
0.02
21.67
ROE (19.31%) VS Industry: 88% outperformed.
0.10
32.91
Profit Margin (16.6%) VS Industry: 100% outperformed.
0.02
16.60
Valuation
Valuation Rating
GNTX's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The Price/Earnings Ratio is 18.89, which indicates a rather expensive current valuation of GNTX.
The Forward Price/Earnings Ratio of 12.64 indicates a correct valuation of GNTX.
With a price book ratio of 2.93, GNTX is valued correctly.
Compared to an average industry Price/Earning Ratio of 14.31, GNTX is valued slightly more expensive.
Compared to an average industry price book ratio of 1.47, GNTX is valued more expensive than its industry peers. 91% of the companies listed in the same industry are valued cheaper.
Compared to an average industry Enterprise Value to EBITDA ratio of 7.17, GNTX is valued more expensive than its industry peers.
VS Industry
Price/Earnings (18.89) VS Industry: 29% outperformed.
168.75
5.15
Price/Book (2.93) VS Industry: 9% outperformed.
56.26
0.28
Enterprise Value/ EBITDA (10.43) VS Industry: 32% outperformed.
70.78
1.15
Growth
Growth Rating
The Earnings Per Share is expected to grow by 17.05% on average over the next 5 years. This is quite good.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
GNTX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.29%.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
GNTX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.71%.
The Earnings Per Share has been growing slightly by 1.06% on average over the past 5 years.
Measured over the past 5 years, GNTX shows a small growth in Revenue. The Revenue has been growing by 1.35% on average per year.
GNTX is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 8.33% yearly.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | 1.06% | -6.24% | 0.71% | 21.73% | 24.5% | 21.02% | 17.05% |
| Revenue | 1.35% | 1.07% | 12.29% | 13.17% | 11.43% | 10.2% | 8.33% |
Health
Health Rating
A Current Ratio of 3.38 indicates that GNTX has no problem at all paying its short term obligations.
GNTX is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.96.
A Quick Ratio of 2.03 indicates that GNTX has no problem at all paying its short term obligations.
GNTX is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.16.
With a Debt to Equity ratio of 0.00, GNTX is one of the better performing companies in its industry. It outperforms 85% of its industry peers.
An Altman-Z score of 14.91 indicates that GNTX is not in any danger for bankruptcy at the moment.
The Altman-Z score of GNTX is much better than the industry average of 2.40. GNTX has a better rating than 93% of its industry peers.
GNTX has a Piotroski-F score of 5.00. This indicates an average health and profitability for GNTX.
VS Industry
Debt/Equity (0) VS Industry: 85% outperformed.
4.58
0.00
Quick Ratio (2.03) VS Industry: 75% outperformed.
0.06
22.85
Current Ratio (3.38) VS Industry: 75% outperformed.
0.06
22.85
Altman-Z (14.91) VS Industry: 93% outperformed.
-7.44
586.94
Dividend
Dividend Rating
GNTX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
GNTX pays out 27.46% of its income as dividend. This is a sustainable payout ratio.
GNTX has been paying a dividend for at least 10 years, so it has a reliable track record.
With a Yearly Dividend Yield of 1.80%, GNTX has a reasonable but not impressive dividend return.
The dividend of GNTX has a limited annual growth rate of 4.64%.
Compared to an average industry Dividend Yield of 3.19, GNTX is paying slightly less dividend.
Compared to the average S&P500 Dividend Yield of 2.72, GNTX is paying slightly less dividend.
VS Industry
Dividend Yield (1.8%) VS Industry: 23% outperformed.
1.39
5.36
GENTEX CORP
NASDAQ:GNTX (5/30/2023, 1:09:55 PM)
26.64
-0.34 (-1.26%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)04-28 2023-04-28/bmo
Earnings (Next)07-20 2023-07-20/bmo
Inst Owners81.17%
Inst Owner Change-5.27%
Ins Owners0.22%
Ins Owner Change18.08%
Market Cap6.23B
Analysts77.33
Price Target32.49 (21.96%)
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.8% |
Dividend Growth(5Y)4.64%
DP27.46%
Div Incr YearsN/A
Div Non Decr Years16
Ex-Date04-05 2023-04-05 (0.12)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.74%
Min EPS beat(2)-5.32%
Max EPS beat(2)10.8%
EPS beat(4)1
Avg EPS beat(4)-8.31%
Min EPS beat(4)-19.53%
Max EPS beat(4)10.8%
Revenue beat(2)1
Avg Revenue beat(2)-1%
Min Revenue beat(2)-3.96%
Max Revenue beat(2)1.96%
Revenue beat(4)2
Avg Revenue beat(4)22.53%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)94.19%
PT rev (1m)0%
PT rev (3m)-1.6%
EPS NQ rev (1m)3.09%
EPS NQ rev (3m)3.06%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.83%
Revenue NQ rev (1m)1.18%
Revenue NQ rev (3m)0.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.89 | ||
| Fwd PE | 12.64 | ||
| P/S | 2.52 | ||
| P/FCF | 36.09 | ||
| P/OCF | 18.14 | ||
| P/B | 2.93 | ||
| P/tB | 4.09 | ||
| EV/EBITDA | 10.43 |
EPS(TTM)1.41
EY5.29%
EPS(NY)2.11
Fwd EY7.91%
FCF(TTM)0.74
FCFY2.77%
OCF(TTM)1.47
OCFY5.51%
SpS10.57
BVpS9.09
TBVpS6.52
PEG (NY)0.87
PEG (5Y)17.78
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.85% | ||
| ROE | 19.31% | ||
| ROIC | 19.55% | ||
| ROICexc | 22.04% | ||
| ROICexgc | 32.25% | ||
| OM | 19.57% | ||
| PM | 16.6% | ||
| GM | 31.77% |
ROICexgc(3y)31.38%
ROICexcg growth 3Y-15.68%
ROICexcg growth 5Y-13.52%
ROICexc(3y)20.31%
ROICexc growth 3Y-13.7%
ROICexc growth 5Y-10.86%
OM growth 3Y-9.81%
OM growth 5Y-7.94%
PM growth 3Y-10.19%
PM growth 5Y-6.31%
GM growth 3Y-4.97%
GM growth 5Y-3.86%
F-Score5
Asset Turnover1.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 177.92% | ||
| Profit Quality | 42.08% | ||
| Current Ratio | 3.38 | ||
| Quick Ratio | 2.03 | ||
| Altman-Z | 14.91 |
F-Score5
WACC8.83%
ROIC/WACC3.65
Cap/Depr(3y)94.62%
Cap/Depr(5y)91.43%
Profit Quality(3y)86.74%
Profit Quality(5y)93.03%
Growth
EPS 1Y0.71%
EPS 3Y-6.24%
EPS 5Y1.06%
EPS growth Q2Q13.51%
EPS Next Y21.73%
EPS Next 2Y24.5%
EPS Next 3Y21.02%
EPS Next 5Y17.05%
Revenue growth 1Y12.29%
Revenue growth 3Y1.07%
Revenue growth 5Y1.35%
Revenue growth Q2Q17.62%
Revenue Next Year13.17%
Revenue Next 2Y11.43%
Revenue Next 3Y10.2%
Revenue Next 5Y8.33%
EBIT growth 1Y-5.81%
EBIT growth 3Y-8.84%
EBIT growth 5Y-6.7%
EBIT Next Year47.47%
EBIT Next 3Y25.17%
EBIT Next 5Y17.7%
FCF growth 1Y-61.82%
FCF growth 3Y-23.39%
FCF growth 5Y-13.87%
OCF growth 1Y-31.91%
OCF growth 3Y-12.57%
OCF growth 5Y-7.56%
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA